104 related articles for article (PubMed ID: 32679349)
1. Systemic Corticosteroid-Related Complications and Costs in Adults with Persistent Asthma.
Zeiger R; Sullivan P; Chung Y; Kreindler JL; Zimmerman NM; Tkacz J
J Allergy Clin Immunol Pract; 2020; 8(10):3455-3465.e13. PubMed ID: 32679349
[TBL] [Abstract][Full Text] [Related]
2. Systemic Corticosteroid-related Adverse Outcomes and Health Care Resource Utilization and Costs Among Patients with Chronic Rhinosinusitis with Nasal Polyposis.
Davis GE; Zeiger RS; Emmanuel B; Chung Y; Tran TN; Evans KA; Chen S; Katial R; Kreindler JL; Tkacz J
Clin Ther; 2022 Sep; 44(9):1187-1202. PubMed ID: 36057475
[TBL] [Abstract][Full Text] [Related]
3. Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma.
Sullivan PW; Ghushchyan VH; Skoner DP; LeCocq J; Park S; Zeiger RS
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1541-1551.e9. PubMed ID: 33290914
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma.
Lefebvre P; Duh MS; Lafeuille MH; Gozalo L; Desai U; Robitaille MN; Albers F; Yancey S; Ortega H; Forshag M; Lin X; Dalal AA
J Allergy Clin Immunol; 2015 Dec; 136(6):1488-1495. PubMed ID: 26414880
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma.
Voorham J; Xu X; Price DB; Golam S; Davis J; Zhi Jie Ling J; Kerkhof M; Ow M; Tran TN
Allergy; 2019 Feb; 74(2):273-283. PubMed ID: 29987879
[TBL] [Abstract][Full Text] [Related]
6. Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States.
Settipane RA; Kreindler JL; Chung Y; Tkacz J
Ann Allergy Asthma Immunol; 2019 Dec; 123(6):564-572.e3. PubMed ID: 31494235
[TBL] [Abstract][Full Text] [Related]
7. Association of low-dosage systemic corticosteroid use with disease burden in asthma.
Matsunaga K; Adachi M; Nagase H; Okoba T; Hayashi N; Tohda Y
NPJ Prim Care Respir Med; 2020 Aug; 30(1):35. PubMed ID: 32753647
[TBL] [Abstract][Full Text] [Related]
8. Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma.
Casale TB; Corbridge T; Germain G; Laliberté F; MacKnight SD; Boudreau J; Duh MS; Deb A
Allergy Asthma Clin Immunol; 2024 Mar; 20(1):25. PubMed ID: 38532489
[TBL] [Abstract][Full Text] [Related]
9. Effects of systemic corticosteroids on blood eosinophil counts in asthma: real-world data.
Ortega H; Llanos JP; Lafeuille MH; Duh MS; Germain G; Lejeune D; Sama S; Bell C; Hahn B
J Asthma; 2019 Aug; 56(8):808-815. PubMed ID: 30130418
[No Abstract] [Full Text] [Related]
10. Use of inhaled corticosteroids and healthcare costs in mild persistent asthma.
Colice G; Wu EQ; Birnbaum H; Daher M; Maryna M
J Asthma; 2007; 44(6):479-83. PubMed ID: 17654136
[TBL] [Abstract][Full Text] [Related]
11. Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma.
Tran TN; MacLachlan S; Hicks W; Liu J; Chung Y; Zangrilli J; Rubino A; Ganz ML
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):338-346.e3. PubMed ID: 32569754
[TBL] [Abstract][Full Text] [Related]
12. Prioritizing Systemic Corticosteroid Treatments to Mitigate Relapse in Adults With Acute Asthma: A Systematic Review and Network Meta-analysis.
Rowe BH; Kirkland SW; Vandermeer B; Campbell S; Newton A; Ducharme FM; Villa-Roel C
Acad Emerg Med; 2017 Mar; 24(3):371-381. PubMed ID: 27664401
[TBL] [Abstract][Full Text] [Related]
13. Age and Sex Associations with Systemic Corticosteroid-Induced Morbidity in Asthma.
Barry LE; O'Neill C; Patterson C; Sweeney J; Price D; Heaney LG
J Allergy Clin Immunol Pract; 2018; 6(6):2014-2023.e2. PubMed ID: 29684579
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
15. Burden of systemic glucocorticoid-related complications in severe asthma.
Lefebvre P; Duh MS; Lafeuille MH; Gozalo L; Desai U; Robitaille MN; Albers F; Yancey S; Ortega H; Forshag M; Lin X; Dalal AA
Curr Med Res Opin; 2017 Jan; 33(1):57-65. PubMed ID: 27627132
[TBL] [Abstract][Full Text] [Related]
16. Use of nebulized inhaled corticosteroids among older adult patients: an assessment of outcomes.
Marcus P; Oppenheimer EA; Patel PA; Katz LM; Doyle JJ
Ann Allergy Asthma Immunol; 2006 May; 96(5):736-43. PubMed ID: 16729789
[TBL] [Abstract][Full Text] [Related]
17. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
[TBL] [Abstract][Full Text] [Related]
18. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
19. Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus.
Kabadi S; Yeaw J; Bacani AK; Tafesse E; Bos K; Karkare S; DeKoven M; Vina ER
Lupus; 2018 Oct; 27(11):1799-1809. PubMed ID: 30068254
[TBL] [Abstract][Full Text] [Related]
20. Treatment effectiveness of inhaled corticosteroids and leukotriene modifiers for patients with asthma: an analysis from managed care data.
Allen-Ramey FC; Duong PT; Goodman DC; Sajjan SG; Nelsen LM; Santanello NC; Markson LE
Allergy Asthma Proc; 2003; 24(1):43-51. PubMed ID: 12635577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
